(File Photo: Source for Photo: This Wednesday, March 1, 2023 photo shows a vial of Eli Lilly’s Humalog insulin in New York. Eli Lilly will cut prices for some older insulins later this year and immediately give more patients access to a cap on costs they pay to fill prescriptions. The moves announced March 1, 2023 promise critical relief to some people with diabetes who can face annual costs of more than $1,000 for insulin they need in order to live. Lilly’s changes also come as lawmakers and patient advocates pressure drugmakers to do something about soaring prices. (AP Photo/Pablo Salinas)

Noah Haswell, Beaver County Radio News

(Allegheny County, PA) A lawsuit against some drug companies and pharmacies filed within the past week by the Allegheny County District Attorney’s Office alleges that companies artificially inflated the cost of insulin prices, all while production costs remained stable. Allegheny County District Attorney Stephen Zappala stated in the filing that while some costs for both goods and services have gone up less than twice more, some medications for diabetes have increased ten times more. According to Zappala, some people are spending thousands of dollars a month on insulin when it’s costing companies as little as $2 per vial to make. The lawsuit from Zappala names companies like CVS, Eli Lilly and United Healthcare and getting this case before a jury in federal court is the next goal for those involved in this lawsuit.